James K. Burmester
Corresponding Author: James K. Burmester
PhD; Center for Human Genetics; Marshfield Clinic Research Foundation; 1000 North Oak Avenue; Marshfield
WI 54449;
Name/email consistency: high
- Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses. Burmester, J.K., Berg, R.L., Glurich, I., Yale, S.H., Schmelzer, J.R., Caldwell, M.D. Clin. Med. Res (2011)
- DMET microarray technology for pharmacogenomics-based personalized medicine. Burmester, J.K., Sedova, M., Shapero, M.H., Mansfield, E. Methods Mol. Biol. (2010)
- Small molecule antagonists of the TGF-beta1/TGF-beta receptor binding interaction. Burmester, J.K., Salzman, S.A., Zhang, K.Q., Dart, R.A. Med. Oncol. (2006)
- Analysis of candidate genes for prostate cancer. Burmester, J.K., Suarez, B.K., Lin, J.H., Jin, C.H., Miller, R.D., Zhang, K.Q., Salzman, S.A., Reding, D.J., Catalona, W.J. Hum. Hered. (2004)